Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Microsatellite instability as indicator of MSH2 gene mutation in patients with upper urinary tract transitional cell carcinoma.

× No keyword cloud information.

10 in total

1. Spectrum of molecular alterations in colorectal, upper urinary tract, endocervical, and renal carcinomas arising in a patient with hereditary non-polyposis colorectal cancer.

Authors: Pierre Mongiat-Artus; Catherine Miquel; Jean-François Fléjou; Florence Coulet; Jérôme Verine; Olivier Buhard; Hany Soliman; Pierre Teillac; Françoise Praz
Journal: Virchows Arch Date: 2006-04-26 Impact factor: 4.064

Review 2. Prognostic factors for upper urinary tract urothelial carcinoma.

Authors: Thomas F Chromecki; Karim Bensalah; Mesut Remzi; Grégory Verhoest; Eugene K Cha; Douglas S Scherr; Giacomo Novara; Pierre I Karakiewicz; Shahrokh F Shariat
Journal: Nat Rev Urol Date: 2011-07-05 Impact factor: 14.432

3. Genetic polymorphisms on 8q24.1 and 4p16.3 are not linked with urothelial carcinoma of the bladder in contrast to their association with aggressive upper urinary tract tumours.

Authors: David R Yates; Morgan Rouprêt; Sarah J Drouin; Marie Audouin; Géraldine Cancel-Tassin; Eva Comperat; Marc-Olivier Bitker; Olivier Cussenot
Journal: World J Urol Date: 2012-09-28 Impact factor: 4.226

Review 4. Genetic counseling considerations in the evaluation of families for Lynch syndrome--a review.

Authors: Scott M Weissman; Cecelia Bellcross; Christina Chimera Bittner; Mary E Freivogel; Joy Larsen Haidle; Pardeep Kaurah; Anna Leininger; Selvi Palaniappan; Kelle Steenblock; Thuy M Vu; Molly S Daniels
Journal: J Genet Couns Date: 2010-10-08 Impact factor: 2.537

5. Quantitative analysis of the association between sulfotransferase isoform 1A1 polymorphism and risk of urothelial carcinoma.

Authors: Kang Liu; Jiaxin Ye; Yuan Huang; Chao Qin; Pu Li; Bianjiang Liu; Jie Li; Changjun Yin
Journal: Mol Clin Oncol Date: 2014-09-01

10. Combination of pembrolizumab and BCG treatment after endoscopic ablation of high-risk superficial upper urinary tract urothelial carcinoma in patients not candidates for radical nephroureterectomy: protocol for phase-II study.

Authors: Marcus L Jamil; Mustafa Deebajah; Akshay Sood; Shaheen Alanee
Journal: BMJ Open Date: 2019-12-03 Impact factor: 2.692

10 in total

Microsatellite instability as indicator of MSH2 gene mutation in patients with upper urinary tract transitional cell carcinoma.

1. Spectrum of molecular alterations in colorectal, upper urinary tract, endocervical, and renal carcinomas arising in a patient with hereditary non-polyposis colorectal cancer.

Review 2. Prognostic factors for upper urinary tract urothelial carcinoma.

3. Genetic polymorphisms on 8q24.1 and 4p16.3 are not linked with urothelial carcinoma of the bladder in contrast to their association with aggressive upper urinary tract tumours.

Review 4. Genetic counseling considerations in the evaluation of families for Lynch syndrome--a review.

5. Quantitative analysis of the association between sulfotransferase isoform 1A1 polymorphism and risk of urothelial carcinoma.

6. Upper tract urothelial carcinomas: frequency of association with mismatch repair protein loss and lynch syndrome.

7. Prognostic value of AIB1 and EIF5A2 in intravesical recurrence after surgery for upper tract urothelial carcinoma.

8. Low frequency of defective mismatch repair in a population-based series of upper urothelial carcinoma.

Review 9. Upper urinary tract disease: what we know today and unmet needs.

10. Combination of pembrolizumab and BCG treatment after endoscopic ablation of high-risk superficial upper urinary tract urothelial carcinoma in patients not candidates for radical nephroureterectomy: protocol for phase-II study.